⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Biocodex Mexico and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Biocodex Mexico
↗Mexico City, Mexico
Biocodex Mexico is a subsidiary of the French family-owned pharmaceutical company Biocodex, established in 2014 to expand the group's presence in the Mexican market. The company focuses on three primary pillars: microbiota care, orphan diseases, and women's health, leveraging the group's heritage as the pioneer of the probiotic yeast strain Saccharomyces boulardii CNCM I-745.
In Mexico, the company is recognized for its work in gastroenterology and pediatrics, with key products such as Floratil. It actively engages in medical education through initiatives like the Biocodex Microbiota Institute and Biocodex Academy, providing healthcare professionals with scientific evidence and clinical research updates.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Microbiota care, Orphan diseases, Women's health
SIZE & FINANCIALS
Employees:51-200
Founded:2014
Ownership:subsidiary
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Probiotics, Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Biocodex (France)
Key Partnerships:Local medical associations for microbiota education
COMPETITION
Position:Niche Player
Competitors:Zentiva, Adare Pharmaceuticals
LEADERSHIP
Key Executives:
Nicolas Coudurier - Global CEO
LINKS
Website:biocodex.mx
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Biocodex Mexico. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.